Captrust Financial Advisors Tenaya Therapeutics, Inc. Call Options Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNYA
# of Institutions
91Shares Held
35.2MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$12.1 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$6.53 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$2.38 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.74MShares$2.25 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $53.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...